Player FM 앱으로 오프라인으로 전환하세요!
TMA: Meera Sridharan, M.D., Ph.D.
Manage episode 292791115 series 2908385
(00:32):
Before we get started, I'm really interested, could you give me a little bit of background on yourself and, uh, just where you work at Mayo Clinic?
(01:31):
So before we start talking about the tests, can you just tell me a little bit about TMA and in that disease state itself?
(03:08):
As we talk very specifically about this testing, so can you give me a brief overview of the assays we're using here at Mayo clinic to diagnose this disease state?
(05:12):
So this testing is really comprehensive and that it covers what you said, classic and alternative, correct? And that it's kind of making sure that anything that's outside of the norm, we're picking up in that one comprehensive test so you're not having to kind of pick through bits and pieces with a bunch of single individual tests. Am I correct and understand kind of how you brought that up?
(08:39):
As you get those results back, how does that affect how you treat a patient? What are the treatments for them as, as you go through this, once you've made that decision?
(09:35):
So there's a lot of movement in this space that is really probably driving the need for a lot of understanding this complement testing and seeing that full clinical picture, because you have to know you now have different therapies to choose from?
295 에피소드
Manage episode 292791115 series 2908385
(00:32):
Before we get started, I'm really interested, could you give me a little bit of background on yourself and, uh, just where you work at Mayo Clinic?
(01:31):
So before we start talking about the tests, can you just tell me a little bit about TMA and in that disease state itself?
(03:08):
As we talk very specifically about this testing, so can you give me a brief overview of the assays we're using here at Mayo clinic to diagnose this disease state?
(05:12):
So this testing is really comprehensive and that it covers what you said, classic and alternative, correct? And that it's kind of making sure that anything that's outside of the norm, we're picking up in that one comprehensive test so you're not having to kind of pick through bits and pieces with a bunch of single individual tests. Am I correct and understand kind of how you brought that up?
(08:39):
As you get those results back, how does that affect how you treat a patient? What are the treatments for them as, as you go through this, once you've made that decision?
(09:35):
So there's a lot of movement in this space that is really probably driving the need for a lot of understanding this complement testing and seeing that full clinical picture, because you have to know you now have different therapies to choose from?
295 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.